Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Jul 15;349(Pt 2):427–434. doi: 10.1042/0264-6021:3490427

Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.

V A Nguyen 1, J Chen 1, F Hong 1, E J Ishac 1, B Gao 1
PMCID: PMC1221165  PMID: 10880341

Abstract

Interferons (IFNs) have been used in the treatment of viral hepatitis. However, their effectiveness is much reduced (<10%) in alcoholics. The mechanism underlying this resistance remains unknown. Here, we report that IFN-alpha/beta and IFN-gamma rapidly activate the JAK-STAT1 (Janus kinase-signal transducer and activator transcription factor 1) and p42/44 mitogen-activated protein kinase (p42/44 MAPK) in freshly isolated rat hepatocytes. Treatment of hepatocytes with 25-100 mM ethanol for 30 min inhibited IFN-beta- or IFN-gamma-induced STAT1 activation and tyrosine phosphorylation. The inhibitory effect of ethanol was not reversed by pretreatment with either sodium vanadate, a non-selective tyrosine phosphatase inhibitor, or with MG132, a specific proteasome inhibitor. This suggests that protein tyrosine phosphatases or the ubiquitin-proteasome pathway are not involved in the inhibitory action of ethanol. In contrast with the JAK-STAT signalling pathway, acute ethanol exposure significantly potentiated IFN-beta or IFN-gamma-induced activation of p42/44 MAPK, and caused marked activation of protein kinase C (PKC). Inhibition of PKC partially antagonized ethanol attenuation of IFN-induced STAT1 activation, suggesting that PKC may be involved. Taken together, these findings suggest that the ability of biologically relevant concentrations of ethanol (less than 100 mM) to markedly inhibit IFN-activated STAT1 is one of the cellular mechanisms responsible for the observed resistance of IFN therapy in alcoholics.

Full Text

The Full Text of this article is available as a PDF (287.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burfoot M. S., Rogers N. C., Watling D., Smith J. M., Pons S., Paonessaw G., Pellegrini S., White M. F., Kerr I. M. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem. 1997 Sep 26;272(39):24183–24190. doi: 10.1074/jbc.272.39.24183. [DOI] [PubMed] [Google Scholar]
  2. Chen J., Bao H., Sawyer S., Kunos G., Gao B. Effects of short and long term ethanol on the activation of signal transducer and activator transcription factor 3 in normal and regenerating liver. Biochem Biophys Res Commun. 1997 Oct 29;239(3):666–669. doi: 10.1006/bbrc.1997.7531. [DOI] [PubMed] [Google Scholar]
  3. Chen J., Kunos G., Gao B. Ethanol rapidly inhibits IL-6-activated STAT3 and C/EBP mRNA expression in freshly isolated rat hepatocytes. FEBS Lett. 1999 Aug 20;457(1):162–168. doi: 10.1016/s0014-5793(99)01031-5. [DOI] [PubMed] [Google Scholar]
  4. Christie J. M., Chapman R. W. Combination therapy for chronic hepatitis C: interferon and ribavirin. Hosp Med. 1999 May;60(5):357–361. doi: 10.12968/hosp.1999.60.5.1116. [DOI] [PubMed] [Google Scholar]
  5. Chung J., Uchida E., Grammer T. C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol. 1997 Nov;17(11):6508–6516. doi: 10.1128/mcb.17.11.6508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. David M., Petricoin E., 3rd, Benjamin C., Pine R., Weber M. J., Larner A. C. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science. 1995 Sep 22;269(5231):1721–1723. doi: 10.1126/science.7569900. [DOI] [PubMed] [Google Scholar]
  7. Davis G. L. Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C. Semin Liver Dis. 1999;19 (Suppl 1):49–55. [PubMed] [Google Scholar]
  8. Durbin J. E., Hackenmiller R., Simon M. C., Levy D. E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 1996 Feb 9;84(3):443–450. doi: 10.1016/s0092-8674(00)81289-1. [DOI] [PubMed] [Google Scholar]
  9. Gao B., Jiang L., Kunos G. Transcriptional regulation of alpha(1b) adrenergic receptors (alpha(1b)AR) by nuclear factor 1 (NF1): a decline in the concentration of NF1 correlates with the downregulation of alpha(1b)AR gene expression in regenerating liver. Mol Cell Biol. 1996 Nov;16(11):5997–6008. doi: 10.1128/mcb.16.11.5997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gish R. G. Standards of treatment in chronic hepatitis C. Semin Liver Dis. 1999;19 (Suppl 1):35–47. [PubMed] [Google Scholar]
  11. Haque S. J., Williams B. R. Signal transduction in the interferon system. Semin Oncol. 1998 Feb;25(1 Suppl 1):14–22. [PubMed] [Google Scholar]
  12. Higashi K., Hoek J. B. Ethanol causes desensitization of receptor-mediated phospholipase C activation in isolated hepatocytes. J Biol Chem. 1991 Feb 5;266(4):2178–2190. [PubMed] [Google Scholar]
  13. Hilton D. J. Negative regulators of cytokine signal transduction. Cell Mol Life Sci. 1999 Sep;55(12):1568–1577. doi: 10.1007/s000180050396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Keeffe E. B., Hollinger F. B. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group. Hepatology. 1997 Sep;26(3 Suppl 1):101S–107S. doi: 10.1002/hep.510260718. [DOI] [PubMed] [Google Scholar]
  15. Kraft A. S., Anderson W. B. Characterization of cytosolic calcium-activated phospholipid-dependent protein kinase activity in embryonal carcinoma cells. Effect of retinoc acid-induced differentiation of F9 cells to parietal endoderm. J Biol Chem. 1983 Aug 10;258(15):9178–9183. [PubMed] [Google Scholar]
  16. Lindsay K. L. Therapy of hepatitis C: overview. Hepatology. 1997 Sep;26(3 Suppl 1):71S–77S. doi: 10.1002/hep.510260713. [DOI] [PubMed] [Google Scholar]
  17. Liu M. K., Brownsey R. W., Reiner N. E. Gamma interferon induces rapid and coordinate activation of mitogen-activated protein kinase (extracellular signal-regulated kinase) and calcium-independent protein kinase C in human monocytes. Infect Immun. 1994 Jul;62(7):2722–2731. doi: 10.1128/iai.62.7.2722-2731.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Meinke A., Barahmand-Pour F., Wöhrl S., Stoiber D., Decker T. Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol. 1996 Dec;16(12):6937–6944. doi: 10.1128/mcb.16.12.6937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Meraz M. A., White J. M., Sheehan K. C., Bach E. A., Rodig S. J., Dighe A. S., Kaplan D. H., Riley J. K., Greenlund A. C., Campbell D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996 Feb 9;84(3):431–442. doi: 10.1016/s0092-8674(00)81288-x. [DOI] [PubMed] [Google Scholar]
  20. Mohr L., Tanaka S., Wands J. R. Ethanol inhibits hepatocyte proliferation in insulin receptor substrate 1 transgenic mice. Gastroenterology. 1998 Dec;115(6):1558–1565. doi: 10.1016/s0016-5085(98)70036-8. [DOI] [PubMed] [Google Scholar]
  21. Nguyen V. A., Gao B. Cross-talk between alpha(1B)-adrenergic receptor (alpha(1B)AR) and interleukin-6 (IL-6) signaling pathways. Activation of alpha(1b)AR inhibits il-6-activated STAT3 in hepatic cells by a p42/44 mitogen-activated protein kinase-dependent mechanism. J Biol Chem. 1999 Dec 10;274(50):35492–35498. doi: 10.1074/jbc.274.50.35492. [DOI] [PubMed] [Google Scholar]
  22. Ohnishi K., Matsuo S., Matsutani K., Itahashi M., Kakihara K., Suzuki K., Ito S., Fujiwara K. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol. 1996 Jul;91(7):1374–1379. [PubMed] [Google Scholar]
  23. Okazaki T., Yoshihara H., Suzuki K., Yamada Y., Tsujimura T., Kawano K., Yamada Y., Abe H. Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers. Scand J Gastroenterol. 1994 Nov;29(11):1039–1043. doi: 10.3109/00365529409094883. [DOI] [PubMed] [Google Scholar]
  24. Platanias L. C., Fish E. N. Signaling pathways activated by interferons. Exp Hematol. 1999 Nov;27(11):1583–1592. doi: 10.1016/s0301-472x(99)00109-5. [DOI] [PubMed] [Google Scholar]
  25. Resnicoff M., Rubini M., Baserga R., Rubin R. Ethanol inhibits insulin-like growth factor-1-mediated signalling and proliferation of C6 rat glioblastoma cells. Lab Invest. 1994 Nov;71(5):657–662. [PubMed] [Google Scholar]
  26. Roivainen R., Hundle B., Messing R. O. Ethanol enhances growth factor activation of mitogen-activated protein kinases by a protein kinase C-dependent mechanism. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1891–1895. doi: 10.1073/pnas.92.6.1891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sasaki Y., Wands J. R. Ethanol impairs insulin receptor substrate-1 mediated signal transduction during rat liver regeneration. Biochem Biophys Res Commun. 1994 Feb 28;199(1):403–409. doi: 10.1006/bbrc.1994.1243. [DOI] [PubMed] [Google Scholar]
  28. Schiff E. R. Hepatitis C and alcohol. Hepatology. 1997 Sep;26(3 Suppl 1):39S–42S. doi: 10.1002/hep.510260707. [DOI] [PubMed] [Google Scholar]
  29. Sengupta T. K., Talbot E. S., Scherle P. A., Ivashkiv L. B. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11107–11112. doi: 10.1073/pnas.95.19.11107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shuai K., Schindler C., Prezioso V. R., Darnell J. E., Jr Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science. 1992 Dec 11;258(5089):1808–1812. doi: 10.1126/science.1281555. [DOI] [PubMed] [Google Scholar]
  31. Stancato L. F., Yu C. R., Petricoin E. F., 3rd, Larner A. C. Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat1 transcription factor. J Biol Chem. 1998 Jul 24;273(30):18701–18704. doi: 10.1074/jbc.273.30.18701. [DOI] [PubMed] [Google Scholar]
  32. Stark G. R., Kerr I. M., Williams B. R., Silverman R. H., Schreiber R. D. How cells respond to interferons. Annu Rev Biochem. 1998;67:227–264. doi: 10.1146/annurev.biochem.67.1.227. [DOI] [PubMed] [Google Scholar]
  33. Starr R., Hilton D. J. Negative regulation of the JAK/STAT pathway. Bioessays. 1999 Jan;21(1):47–52. doi: 10.1002/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  34. Stephens J. M., Lumpkin S. J., Fishman J. B. Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes. J Biol Chem. 1998 Nov 20;273(47):31408–31416. doi: 10.1074/jbc.273.47.31408. [DOI] [PubMed] [Google Scholar]
  35. Uddin S., Yenush L., Sun X. J., Sweet M. E., White M. F., Platanias L. C. Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase. J Biol Chem. 1995 Jul 7;270(27):15938–15941. doi: 10.1074/jbc.270.27.15938. [DOI] [PubMed] [Google Scholar]
  36. Xu Y. Y., Bhavani K., Wands J. R., de la Monte S. M. Ethanol inhibits insulin receptor substrate-1 tyrosine phosphorylation and insulin-stimulated neuronal thread protein gene expression. Biochem J. 1995 Aug 15;310(Pt 1):125–132. doi: 10.1042/bj3100125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yoshimura A. The CIS family: negative regulators of JAK-STAT signaling. Cytokine Growth Factor Rev. 1998 Sep-Dec;9(3-4):197–204. doi: 10.1016/s1359-6101(98)00019-7. [DOI] [PubMed] [Google Scholar]
  38. Younossi Z. M., Perrillo R. P. The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C. Semin Liver Dis. 1999;19 (Suppl 1):95–102. [PubMed] [Google Scholar]
  39. Zein N. N. Interferons in the management of viral hepatitis. Cytokines Cell Mol Ther. 1998 Dec;4(4):229–241. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES